Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Fish Oils on Inflammation and Insulin Resistance

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
GlaxoSmithKline
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Philip Kern, University of Kentucky
ClinicalTrials.gov Identifier:
NCT00579436
First received: December 20, 2007
Last updated: August 22, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications: